Background Noninvasive predictors of important outcomes after valve replacement for mitral regurgitation have not been examined in a rheumatic population (in whom the results of valve repair are suboptimal) in the era of chordal preservation. Timing of valve replacement thus remains a difficult question in rheumatic mitral regurgitation.
Methods and Results Of 278 patients followed after valve replacement, 66 had pure or predominant mitral regurgitation, and in 61 of these the etiology was rheumatic. The mean age was 24 years. After a mean follow-up of 24±10 months, the ability of preoperative clinical and echocardiographic data to predict outcome was assessed prospectively, and the possible impact of chordal preservation (n=35) on survival and postoperative left ventricular function was examined retrospectively. There were no perioperative deaths. There were six postoperative deaths, all the result of heart failure and all related to left ventricular dysfunction. The mean probability of survival was .90 at 16 months. In a stepwise Cox proportional hazards regression analysis, the only independent predictor of postoperative death was preoperative end-systolic diameter. According to a logistic model, the probabilities of death (n=6) and death or severe heart failure (n=7) increased abruptly at a preoperative end-systolic diameter of 51 mm (probabilities, T Nhe increasing use of repair techniques has broadened the indications for surgery for mitral regurgitation.1 Specifically, in patients with minimal symptoms and minimal left ventricular enlargement, it might be advisable to "prophylactically" repair mitral regurgitation to prevent progressive left ventricular dilatation and dysfunction.' At the opposite end of the spectrum, patients with severe symptoms and severe preoperative left ventricular dysfunction might benefit from mitral repair because some data suggest that left ventricular function is better preserved after this operation than after valve replacement. [2] [3] [4] [5] Rheumatic mitral regurgitation remains prevalent among the young people of developing countries.6-8 We have recently questioned9 the advisability of repair versus replacement in young patients with rheumatic mitral regurgitation, because the results are not as durable as for other etiologies of mitral regurgitation (eg, myxomatous degeneration),7,l0 because repair may .23 and .31, respectively), and the accuracy of this cut point for predicting outcomes was 97% and 98%, respectively. Multiple linear regression analysis identified a large preoperative endsystolic diameter and the need to use tricuspid annuloplasty as significant independent predictors of postoperative fractional shortening; the use of chordal preservation (n=35) was not a predictor of postoperative fractional shortening. A good outcome was predicted at a preoperative end-systolic diameter of 40 mm: probability of death or heart failure was .0001, and predicted mean postoperative fractional shortening was 0.27 after mitral valve replacement without tricuspid annuloplasty.
Conclusions When preoperative end-systolic diameter is more than 50 mm, a poor postoperative outcome is predicted despite chordal preservation in relatively young patients with rheumatic mitral regurgitation, and alternative strategies should therefore be considered. When preoperative end-systolic diameter is 40 mm or less, an excellent outcome is predicted, and close observation without surgery would appear to be reasonable in the absence of symptoms. (Circulation. 1994; 89:191-197.) Key Words * valves * mitral regurgitation * left ventricle not be feasible in some,7 and because we have found a low incidence of prosthetic valve complications in our patients. 11 Thus, in our relatively young patients with rheumatic mitral regurgitation, valve replacement-with chordal preservation when technically feasible-is performed more often than valve repair, and two questions still frequently arise with regard to timing: How Table 1 . The other five patients had subacute infective endocarditis on a valve that was thought to be myxomatous or previously normal, and they also differed from the primary study group in regard to sex (80% were male, P=.003), body surface area (1.8±0.8 mi2, P=.001), and mitral valve area (6.5±1.9 cm2, P=.02). These patients were excluded from the analysis.
All patients were symptomatic. Only a minority of patients underwent preoperative cardiac catheterization, and coronary angiography was not usually performed because none had angina and only three patients were more than 40 years old; two of these three were male and had coronary angiography that was normal.
Surgery
Operations were performed with the standard techniques of cardiopulmonary bypass, including hemodilution and moderate systemic hypothermia with the myocardium protected with cold crystalloid cardioplegia. A mechanical mitral prosthesis was used in each patient. Although no patient had or received a prosthesis other than in the mitral position, 24 patients underwent concomitant tricuspid annuloplasty; this was performed because of a preoperative tricuspid annulus measurement of .34 mm17 or the presence on color flow mapping of significant tricuspid regurgitation (n=9). Chordae to the posterior mitral leaflet alone were preserved in 26 patients, and chordae to both posterior and anterior mitral leaflets were preserved in 9; in the latter patients, the anterior leaflet was divided into two parts that were anchored separately to the annulus near the commissures, and redundant valve tissue was trimmed. For statistical analysis, the use of chordal preservation techniques was scored as 0 for no preservation, 1 for preservation of posterior leaflet chordae alone, and 2 for preservation of both leaflet chordae. Prosthetic valves used were St Jude (n=43), Medtronic-Hall (n=8), and Carbomedics (n= 10). Details, including the use of chordal preservation, type of prosthesis used, and aortic cross-clamp time, were obtained from operative reports. Data were not recorded regarding chordal preservation in 5 patients and regarding aortic cross-clamp time in 8. Creatine kinase levels were not routinely measured.
Patient Follow-up and Doppler Echocardiography
Doppler two-dimensional echocardiography with Doppler color flow mapping was performed before surgery in each patient using a Hewlett Packard Sonos model 500 or 1000. The mitral regurgitation was judged to be severe in each on the basis of physical examination and either color jet size or, when the jet was laminated along the left atrial wall, observation of a flail leaflet or failure of mitral leaflet coaptation on echocardiography. Studies were recorded on videotape, one for each patient. Serial follow-up studies were performed on the same tape using the same equipment. Return visits to the clinic were scheduled monthly; echocardiographic studies were routinely performed at 3, 6, and 12 months; then yearly; and at more frequent intervals when feasible or when a complication was suspected. All patients except one (who died early) had at least one postoperative echocardiogram, and contact with the patient by either clinic visit or by telephone for those living remote from the hospital was current in all patients except for one patient, who missed only her most recently scheduled clinic visit. Mean±SD duration of follow-up was 24±10 months. The last available echocardiogram was used for the postoperative result (mean±SD, 14±8 months after surgery). Although echocardiograms were recorded prospectively by multiple observers, the present analysis was performed retrospectively by a single observer (D.S.) using the twodimensional images recorded on tape. This observer was not blinded. The two-dimensional images were used to avoid problems with M-mode beams, which were not directed perpendicular to the endocardium.18 Left atrial dimension and left ventricular end-diastolic and end-systolic diameters just above the papillary muscles were measured in the parasternal long-axis view. Although there is a fair correlation between left atrial diameter and both left atrial volume and mitral regurgitation severity,19 the degree of left atrial enlargement may be underestimated in this view.20 Thus, left atrial cross-sectional area was also estimated from the apical four-chamber view.
For the left ventricular measurements, an average was obtained from at least three beats for patients in sinus rhythm and five beats for patients in atrial fibrillation. Paradoxical septal wall motion was not observed on M-mode or twodimensional imaging in any of the latest follow-up studies, although the septum appeared relatively hypokinetic in 12 and akinetic in 3. Preoperative valve areas were determined by two-dimensional echocardiographic planimetry. Postoperative valve areas were estimated with the Doppler pressure-halftime method. Ring leaks were evaluated with color flow mapping from the transthoracic and transesophageal approach; one patient was documented to have a mild (2+) mitral ring leak. There were no other valve-related complications. None of the patients had more than mild tricuspid regurgitation on postoperative color flow mapping; native aortic valve regurgitation was graded on follow-up color Doppler as moderate in 1 patient and mild in 13.
All patients were treated with warfarin and dipyridamole. Digoxin, diuretics, and angiotensin-converting enzyme inhibitors (n=12) were used after surgery at the discretion of the physician caring for the patient when atrial fibrillation or left ventricular dysfunction was present.
Statistical Analysis
Separate outcome variables were death, death and severe heart failure (New York Heart Association functional class 2111) combined, and postoperative left ventricular function measured by echocardiography. Probability of survival was estimated by the Kaplan-Meier method.2' Because the exact dates for death were known, the censoring scheme for the survival analysis was for exact failures and right censoring only. Potential univariate preoperative and intraoperative predictors of death (Table 1) were examined by Cox proportionalhazards regression. Stepwise multivariate Cox proportional hazards regression analysis was then performed to determine which variables were independent predictors of outcome.2' Significant univariate predictors were evaluated first; other variables were then made available for upward stepping, with the criterion for inclusion being Pc.05 according to the log-likelihood ratio test. The resulting Cox model was used to compute the probability of postoperative death for each patient from the following relation:
where So(t) is the baseline survivor function with covariate value x set to 0 at t equal to time to last failure, 13 is the regression coefficient, and x is the covariate value for each patient (for a model with a single significant covariate). Because our primary outcome variable was death versus survival (dichotomous) rather than survival time, outcome probabilities were also computed using stepwise logistic regression analysis:
P=exp(y)/[1 +exp (y)] where y=,30+log&(,81)*xl from the logistic regression analysis.
This analysis allowed for computation of standard errors on the probability estimates, whereas this was not available for the corresponding Cox analysis. The probability values corresponding to the maximum predictive accuracy were obtained from a classification matrix. Univariate and multivariate stepwise linear regression examined correlates (in the above order of clinical, echocardiographic, and then intraoperative) of postoperative fractional shortening (which was used as a continuous variable).
Because the data were normally distributed, values are reported as mean±SD, and a two-tailed value of P<.05 was considered significant.
Results

Baseline Characteristics
As shown in Table 1 Stepwise logistic regression analysis was used to create a model for predicting the probability of postoperative death. As in the Cox analysis, end-systolic diame- Patients for whom data on chordal preservation were unavailable (n=5) did not significantly differ from the other 56 patients with regard to any of the baseline characteristics listed in Table 1 . To further examine the possible effect of missing data on outcomes, the analyses were repeated with scores for chordal preservation imputed alternatively as 0 (no preservation) and 2 (chordae to both leaflets preserved). In neither univariate (P>.33) or multivariate (P>.72) Cox analysis of death and death or heart failure did chordal preservation become significant, nor was postoperative fractional shortening influenced by chordal preservation when either of these two scores (P>.61) was input for the five patients with missing data.
Discussion
This relatively large, prospective, multivariate analysis of survival and left ventricular function after valve replacement for mitral regurgitation yielded a graded risk of poor outcome based on a single preoperative variable: end-systolic diameter. The study is also unique in terms of the young age of patients under study, the pure rheumatic etiology, the large proportion of patients in whom leaflet chordae were preserved, and the .00 SE indicates standard error of the probability. Probabilities computed from logistic and Cox models versus the observed proportion of patients with postoperative death or severe heart failure. The mean probability values corresponding to an endsystolic diameter of 51 mm yielded the maximum predictive accuracy. Values are given for each patient at or above this cut point, followed by the mean values for this and lower ranges of preoperative end-systolic diameter. (Table 4) predicts a postoperative fractional shortening of 0.27 after mitral valve replacement without tricuspid annuloplasty for a patient with a preoperative end-systolic diameter of 40 mm (which agrees with the observed result in Fig 2) . This may provide some guidance as to whether mitral valve replacement can be deferred in asymptomatic patients in whom end-systolic diameter slightly exceeds the normal range (mean+2 SD=36 mm in our laboratory). However, longer follow-up is needed to better answer this 
Role of Chordal Preservation
Accumulating evidence suggests that chordal preservation during prosthetic valve insertion may preserve left ventricular function.2-5,23-27 Although chordae to posterior (n=6) or both (n=1) leaflets were preserved in all except one patient in the present study in whom preoperative end-systolic diameter was >51 mm, results in this subgroup were still poor. We are unable to explain why, even after adjusting for baseline differences in end-systolic diameter, multivariate analysis failed to demonstrate any beneficial effect of chordal preservation (n=35) on either survival or postoperative left ventricular function. The only obvious difference between this and the studies cited above is the higher prevalence of rheumatic disease in the present study. However, neither the present nor any previous study of which we are aware has provided long-term follow-up data on patients randomly assigned to chordal preservation versus no preservation at the time of mitral valve replacement. A large randomized trial is needed to clearly define the long-term clinical importance of chordal preservation.
Study Limitations
Although this was a relatively large prospective study of important outcomes after valve replacement for mitral regurgitation, the number of deaths was small, probably because of the freedom of our young patients from other complicating diseases; this resulted in fairly large confidence intervals around the relative risk (1.13-1.51; P=.000003) for incremental increases in endsystolic diameter. However, outcome in terms of death or severe heart failure was predicted with 98% accuracy by a preoperative end-systolic diameter >51 mm. It is doubtful that invasive parameters used in earlier studies28 would have added significantly to the predictive accuracy of our model, but because this was a noninvasive study, we cannot comment on potential predictors such as pulmonary arterial pressure. Although the patients were followed prospectively, the echocardiographic analysis was nonblinded, and as stated, the analysis of chordal preservation data was nonrandomized. We therefore cannot exclude the potential role of chordal preservation in the preservation of left ventricular function and survival. In addition, we did not study in detail the adequacy of myocardial preservation, and it is possible that this might have affected outcome in the patients with dilated ventricles even though aortic crossclamp time was not a factor in univariate analysis.
Conclusions
In a young group of patients with mostly rheumatic mitral regurgitation who are being considered for valve replacement, how late is too late? When preoperative end-systolic diameter is >51 mm, it is too late to expect long-term symptom-free survival even with chordal preservation. How soon is too soon? In a totally asymptomatic patient, it is probably safe to wait until endsystolic diameter reaches 40 mm, but longer follow-up will be needed to be confident of this.
